Life

Health, science, climate, and society-focused reporting.

Biotech Sector Faces Disruption as Epstein Associate Seeks Comeback Amid FDA Leadership Changes

The latest episode of The Readout LOUD podcast discusses the implications of a Jeffrey Epstein associate's biotech resurgence and the exit of a key FDA figure.

Editorial Staff Mar 12

Life

Assessing the Infrastructure of Youth Mental Health in Light of Gun Violence

Gun violence exposure significantly impacts youth mental health, necessitating a reevaluation of support systems and resources dedicated to affected populations.

Editorial Staff Mar 12

Life

Analysis of Youth Firearm Mortality Trends and Demographic Variations

Recent CDC data indicates significant trends in firearm-related deaths among youth, with nearly 22,000 fatalities over the past decade, highlighting demographic and state variations.

Editorial Staff Mar 12

Life

Current Landscape of Medicaid Expansion Decisions Across States

An interactive map illustrates the status of state-level decisions regarding Medicaid expansion under the Affordable Care Act, updated as of March 12, 2026.

Editorial Staff Mar 12

Life

FDA Implements Unified System for Reporting Adverse Events

The FDA has introduced a new unified system aimed at streamlining the reporting of adverse events. This initiative could have significant implications for regulatory processes and data management in the biotech sector.

Editorial Staff Mar 12

Life

Telehealth Adoption by Mental Health Providers Shows Limited Rural Reach

An analysis of Medicare data reveals that mental health specialists using telehealth have not significantly expanded their services to rural patients, highlighting ongoing accessibility challenges.

Editorial Staff Mar 12

Life

Telehealth Prescribers Under FDA Scrutiny for Compounded Drug Marketing

The FDA's warning regarding compounded weight loss drugs extends scrutiny to medical groups linked with telehealth providers, highlighting potential regulatory impacts.

Editorial Staff Mar 12

Life

NIH Whistleblower Highlights Telehealth GLP-1 Surge

A recent whistleblower report from NIH raises concerns about the rapid expansion of telehealth services related to GLP-1 medications, emphasizing the need for regulatory scrutiny.

Editorial Staff Mar 12

Life

EPA Fluoride Safety Review and State-Level Bans Signal Infrastructure Implications

The EPA's upcoming safety review of fluoride, set for March 2026, aligns with a trend of state-level bans on community water fluoridation, raising concerns about water treatment infrastructure.

Editorial Staff Mar 12

Life

Aldeyra Therapeutics and Short Seller Complaints: An Infrastructure Perspective

The frequency of drugmakers' complaints about short sellers in SEC filings raises questions about regulatory impacts and operational integrity within the pharmaceutical sector.

Editorial Staff Mar 12

Life

FDA Scrutinizes Telehealth Marketing of GLP-1 Drugs

The FDA's increased scrutiny on telehealth marketing for GLP-1 drugs could reshape prescribing practices and impact telehealth companies.

Editorial Staff Mar 12

Life

Potential Establishment of a Federal Office of Men's Health: Implications for Disease Prevention

The push for a federal office dedicated to men's health is gaining traction, which may lead to significant changes in disease prevention strategies.

Editorial Staff Mar 12

Life

Medicare Drug Price Negotiation: Key Operational Insights

The federal government engages in price negotiations for select high-cost drugs under Medicare Part B and Part D, impacting healthcare costs and drug accessibility.

Editorial Staff Mar 11

Life

FDA Grants Leucovorin Approval for Rare Disorder Without Traditional Trial Data

The FDA's recent approval of Leucovorin for a rare disorder, lacking conventional trial data, prompts a reevaluation of drug evaluation protocols and potential impacts on infrastructure.

Editorial Staff Mar 11

Life

FDA Issues Warning to Novo Nordisk Amid Lilly's Strategic Expansion in China

The FDA has issued a warning to Novo Nordisk regarding product safety, while Lilly is increasing its investment in China to bolster market presence.

Editorial Staff Mar 11

Life

Billionaire's Initiative Aims to Enhance Scientific Research for AI Applications

Seemay Chou and Becky Pferdehirt propose a transformative approach through Radial, focusing on improving scientific methodologies to better serve AI development.

Editorial Staff Mar 11

Life

U.S. Health Spending Outpaces Other Nations but Growth Rate Lags

An analysis reveals that while the U.S. maintains the highest total health spending, eight OECD countries have surpassed it in per-person spending growth rates.

Editorial Staff Mar 11

Life

Impact of Reduced NIH Funding on Red States' Health Infrastructure

Recent reports indicate that states with Republican leadership are experiencing significant reductions in NIH funding, which may affect health outcomes and research capabilities.

Editorial Staff Mar 11

Life

Radial Nonprofit Launches with $500 Million to Enhance Scientific Processes for AI Integration

Radial, a new nonprofit organization, has secured at least $500 million in funding aimed at modernizing scientific processes to better accommodate artificial intelligence technologies.

Editorial Staff Mar 11

Life

Concerns Over AI Agent Validation in Health Care at HIMSS 2026

At HIMSS 2026, experts express concerns regarding the rapid deployment of AI agents in health care, highlighting the critical need for validation of these technologies.

Editorial Staff Mar 11